Merus (MRUS) Stock Highlights

39.45 | -0.5%

2025-01-21 03:18:08

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus only reportable segment comprising the discovery and development of innovative bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Statistics

Range Today

38.71 40.12

Volume Today 639K

Range 1 Year

31.27 61.61

Volume 1 Year 172.99M

Range 3 Year

12.03 61.61

Volume 3 Year 333.24M

Range 10 Year

7.255 61.61

Volume 10 Year 472.07M

Highlights

Market Capitalization 2.7B (mid)

Floating Shares 62.9M

Current Price 39.45

Price To Earnings -9.85

Price To Revenue 58.26

Price To Book 3.84

Earnings Per Share -4.03

Payout Ratio 0%

Performance

Latest -0.5%

1 Month -7.85%

3 Months -24.61%

6 Months -31.91%

1 Year +19.91%

3 Years +39.99%

5 Years +120.64%

10 Years +304.62%

Benchmarks

Market Capitalization

61 / 368

Gross Profits

241 / 278

Total Revenue

129 / 300

Total Rank

335 / 368

Free Cashflow

264 / 352

Performance 5 years

45 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.